Cellectis (CLLS) EBT (2015 - 2026)
Cellectis (CLLS) posted quarterly EBT of -$8.8 million for Q1 2026, down 473.36% year-over-year from $2.4 million in Q1 2025, and up 91.67% quarter-over-quarter from -$106.1 million in Q4 2025.
Cellectis (CLLS) EBT (2015 - 2026) Analysis & Trends
Cellectis' EBT history runs 12 years deep, the most recent figure standing at -$8.8 million for Q1 2026.
- In Q1 2026, EBT fell 473.36% year-over-year to -$8.8 million; the TTM figure through Mar 2026 stood at -$76.8 million (down 34.55% YoY), while the FY2025 annual figure was -$68.0 million, down 85.02% from the prior year.
- EBT for Q1 2026 stood at -$8.8 million, up from -$106.1 million in the prior quarter.
- The five-year high for EBT was $22.4 million in Q3 2025, with the low at -$106.1 million in Q4 2025.
- The 5-year median for EBT is -$8.8 million (2026), against an average of -$18.3 million.
- The sharpest annual moves came in 2023 and 2025: EBT slumped 3000.46% in 2023, then surged 191.03% in 2025.
- Cellectis' EBT stood at -$2.8 million in 2022, then plunged by 3000.46% to -$88.0 million in 2023, then soared by 52.63% to -$41.7 million in 2024, then sank by 154.56% to -$106.1 million in 2025, then jumped by 91.67% to -$8.8 million in 2026.
- Business Quant data shows CLLS's EBT at -$8.8 million in Q1 2026, -$106.1 million in Q4 2025, and $22.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 1.39 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.53 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 541.00 Mn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | -644.37 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 312.46 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -2,828.29 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 81.49 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 177.81 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | -11.37 Mn |
| 10 | Cellectis | 306.61 Mn | 120.95 Mn | - | -8.83 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -8.83 Mn |
| Dec 31, 2025 | -106.06 Mn |
| Sep 30, 2025 | 22.41 Mn |
| Jun 30, 2025 | 15.65 Mn |
| Mar 31, 2025 | 2.37 Mn |
| Dec 31, 2024 | -41.66 Mn |
| Sep 30, 2024 | 7.70 Mn |
| Jun 30, 2024 | -25.50 Mn |
| Mar 31, 2024 | 11.65 Mn |
| Dec 31, 2023 | -87.96 Mn |
| Sep 30, 2023 | -38.84 Mn |
| Jun 30, 2023 | 3.10 Mn |
| Mar 31, 2023 | -17.48 Mn |
| Dec 31, 2022 | -2.84 Mn |
| Sep 30, 2022 | -23.37 Mn |
| Jun 30, 2022 | -15.63 Mn |
| Mar 31, 2022 | -5.62 Mn |
| Dec 31, 2021 | -7.06 Mn |
| Sep 30, 2021 | -44.56 Mn |
| Jun 30, 2021 | -36.17 Mn |